The only way to safeguard antibiotic use is to develop faster diagnostics at the point of care. Our solution uses NANOPLEX™ technology to rapidly identify bacterial infection within 15 minutes.

NANOPLEX enables bacterial ID and enumeration at the point of care; key information for at risk demographics (e.g. pregnant women and elderly).

  • Antimicrobial stewardship
  • Microbial diagnostics
  • Infection prevention
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

  • Company
  • Academia
  • Institute
  • NGO
  • Government

  • License
  • Co-develop
  • Joint Venture
  • Outsource
  • Sell

Funding organisation:

    Infectious disease area:

      Geographic origin:

        We are interested in collaborations with academic groups, antibiotic and diagnostic developers.

        FluoretiQ is developing the NANOPLEX technology platform to reduce the time to correctly diagnose bacterial infections from 2 days to 15 mins.

        NANOPLEX™ has potential applications in: • Urinary Tract Infection • Antibiotic Susceptibility Testing • Sexually Transmitted Diseases • Veterinary • Food/ Drink Quality Control and Quality Assurance • Oncology

        What is going on with AMR?
        Stay tuned with remarkable global AMR news and developments!